Need help finding what you are looking for?
Contact Us
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1461278
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1461278
Peripheral Vascular Devices Market, By Product Type, By End User, By Geography
PUBLISHED:
PAGES: 185 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Global peripheral vascular devices market is estimated to be valued at USD 12.68 Bn in 2024 and is expected to reach USD 19.45 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.3% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2023/2024: | US$ 12.68 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2023/2024 to 2030/2031 CAGR: | 6.30% | 2030/2031 Value Projection: | US$ 19.45 Bn |
Peripheral Vascular Devices Market Share (%), By Region, 2024
Global peripheral vascular devices market has been witnessing steady growth over the past few years owing to increasing geriatric population and prevalence of lifestyle diseases. Peripheral vascular devices are majorly used in diagnosis and treatment of peripheral artery disease (PAD), a condition characterized by narrowed arteries reducing blood flow to limbs. Rising research activities focusing on development of advanced technologies such as drug-eluting stents and scoring balloon catheters is expected to positively influence the market expansion during the forecast period. Favorable reimbursement scenario in developed economies and growing awareness regarding early diagnosis are supplementing the market growth. However, high cost of treatment accompanied with certain procedures and strict regulatory approvals are some of the major factors impeding the market growth.
Market Dynamics:
Global peripheral vascular devices market growth is primarily driven by increasing geriatric population prone to chronic diseases, growing prevalence of lifestyle diseases such as diabetes, obesity leading to peripheral artery disease as well as rising research initiatives for development of innovative devices. High risk of contracting PAD in diabetic patients boosts the need for effective diagnostic and interventional procedures, thereby, fueling demand for peripheral vascular devices. However, high cost of technologically advanced devices and treatment procedures along with stringent regulatory policies for new product approvals are major challenges restraining the market growth. Meanwhile, ongoing research & development activities embarked by key players to introduce bio-absorbable stents and efficient drug delivery systems present lucrative opportunities for market players over the forecast period.
Key Features of the Study:
- This report provides in-depth analysis of the global peripheral vascular devices market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global peripheral vascular devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study includes Abbott Laboratories, Boston Scientific Corporation, Angioscore, Emboline Inc., Becton Dickinson and Company, Cook Group Inc., Cordis Corporation, Covidien PLC, Edward Lifesciences Corporation, Medtronic Plc, St. Jude Medical, Bayer AG, Teleflex Medical, Koninklijke Philips N.V., and Cardio Flow, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global peripheral vascular devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peripheral vascular devices market.
Detailed Segmentation-
- Product Type:
- Peripheral Vascular Stents
- Peripheral Transluminal Angioplasty Balloon Catheters
- PTA Guidewires
- Atherectomy Devices
- Chronic Total Occlusion Devices
- Aortic Stents
- Synthetic Surgical Grafts
- Others
- End User:
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
- Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Abbott Laboratories
- Boston Scientific Corporation
- Angioscore
- Emboline Inc.
- Becton Dickinson and Company
- Cook Group Inc.
- Cordis Corporation
- Covidien PLC
- Edward Lifesciences Corporation
- Medtronic Plc
- Jude Medical
- Bayer AG.
- Teleflex Medical
- Koninklijke Philips N.V.
- Cardio Flow, Inc.
Product Code: CMI391
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Technology Overview
- Regulatory Scenario
- PEST Analysis
4. Global Peripheral Vascular Devices Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Impact on Supply and Demand
- COVID-19 Impact on the market
5. Global Peripheral Vascular Devices Market, By Product Type, 2019 - 2031, (USD BN)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Peripheral Vascular Stents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Peripheral Transluminal Angioplasty Balloon Catheters
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- PTA Guidewires
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Atherectomy Devices
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Chronic Total Occlusion Devices
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Aortic Stents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Synthetic Surgical Grafts
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
6. Global Peripheral Vascular Devices Market, By End User, 2019 - 2031, (USD BN)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Ambulatory Surgical Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
7. Global Peripheral Vascular Devices Market, By Region, 2019 - 2031, (USD BN)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD BN)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Abbot Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Angioscore
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Emboline Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Becton Dickinson, and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cook Group Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cordis Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Covidien PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Edward Lifesciences Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Medtronic Plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- St. Jude Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Teleflex Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Koninklijke Philips N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cardio Flow, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.